ДЖЕНЕРИЧЕСКИЕ СТАТИНЫ В КЛИНИЧЕСКОЙ ПРАКТИКЕ: ДЕШЕВЫЕ ЗАМЕНИТЕЛИ ИЛИ ДОСТОЙНАЯ АЛЬТЕРНАТИВА БРЕНДАМ. АТОРВАСТАТИН

Abstract

The relevance of cardiovascular disease in the world and in Russia causes including calls for patient compliance with medical recommendations. Compliance, in turn, depends on the cost of medicines. From an economic point of view generic drugs appear in a very favorable light, price is several times lower than the original’s. However, comparative studies of therapeutic equivalence of generic and branded drugs are very few. This paper presents a comparative clinical evaluation of the original drug atorvastatin and its analogue (Torvakard (Zentiva)), the lipid-lowering and endothelium-protective effects of both drugs were studied.

Keywords

• комплаенс
• дженерики
• терапевтическая эквивалентность
• торвакард